29.08.2014 • NewsMergers & Acquisitions (M&A)AllerganBotox

Delaware Judge Fast-tracks Valeant Suit Over Allergan Meeting

A judge in the US state of Delaware has granted a request by Valeant Pharmaceuticals International and Pershing Square Capital Management, the investment vehicle of activist shareholder Bill Ackman, for expedited proceedings in a dispute over a special meeting dispute with Botox manufacturer Allergan.

Andre Bouchard of Delaware's Court of Chancery has scheduled a three-day trial to start Oct. 6. Allergan had proposed a Nov. 24 trial.

Allergan is the subject of a $52 billion takeover attempt spearheaded by Ackman. The investor is seeking the meeting to try to replace the bulk of Allergan board members with his own slate of directors.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.